Pulmcrit Wee- Vasopressin vs. norepinephrine for vasoplegic shock after cardiac surgery

Patients in the VANISH trial treated with vasopressin had a lower incidence of renal failure requiring hemodialysis. However, this was a secondary endpoint which seemed to contradict the primary endpoint (defined as a milder degree of kidney injury). New data may clarify this controversy.

EMCrit by Josh Farkas.

from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2foyuYK